Related Experiment Video
Updated: May 27, 2026

09:39
Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
Published on: February 7, 2021
Compositional optimization and safety assessment of a hydrogel patch as a transcutaneous immunization device.
Kazuhiko Matsuo1, Yumiko Ishii, Ying-Shu Quan
1Laboratory of Biotechnology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565–0871, Japan.
Biological & Pharmaceutical Bulletin
|December 2, 2011
Summary
A novel hydrogel patch for transcutaneous immunization (TCI) optimizes antigen penetration through the skin. This safe and effective TCI system shows promise for future human vaccination strategies.
Area of Science:
- Biomaterials Science
- Immunology
- Dermatology
Background:
- Transcutaneous immunization (TCI) offers a non-invasive vaccination route.
- Previous hydrogel patch formulations enhanced antigen (Ag) penetration through the stratum corneum (SC).
- Optimization and safety assessment of the hydrogel patch formulation are crucial for clinical translation.
Purpose of the Study:
- To optimize the composition of a hydrogel patch for transcutaneous immunization.
- To assess the safety profile of the optimized hydrogel patch formulation.
- To evaluate the efficacy of the hydrogel patch in eliciting Ag-specific immune responses.
Main Methods:
- Formulation of hydrogel patches with varying water content ratios.
- Assessment of antigen penetration through the stratum corneum.
- Evaluation of Ag-specific immune responses.
- Monitoring for local and systemic adverse reactions.
Main Results:
- A hydrogel patch with a 5% water content ratio demonstrated superior immune response induction compared to other compositions.
- Optimal moisture content in the hydrogel patch facilitates SC hydration, promoting antigen penetration.
- TCI using the hydrogel patch resulted in minimal local and systemic adverse reactions.
Conclusions:
- The optimized hydrogel patch formulation enhances antigen delivery for effective transcutaneous immunization.
- The developed TCI system exhibits a favorable safety profile.
- Further translational research is underway to evaluate the safety and efficacy in human subjects.